维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="Lubaroff DM"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Supression of prostate cancer invasive potential and metalloproteinase activity by E-cadherin transfection 显示文摘	Luo J Lubaroff DM Hendrix MJ	1999	Cancer Res1999，59，15：	1
2	Clinical protocol: phase I study of an adenovirus/prostate-specific antigen vaccine in men with metastatic prostate cancer 显示文摘	Lubaroff DM Konety B Link BK	2006	Hum Gene Ther2006，17，：	1
3	Supression of prostate cancer invasive potential and matrix metalloproteinase activity by E-cadherin transfection 显示文摘	Luo J Lubaroff DM Hendrix MJ	1999	Cancer Res1999，59，15：	1
4	Supression of prostate cancer invasive protential and matrix metalloproteinase activity by E - cadherin transfection 显示文摘	Luo J Lubaroff DM Hendrix MJ	1999	Cancer Res1999，59，15：	1
5	Prostate cancer vaccines in clinical trials显示文摘	Lubaroff DM	2012	Expert Rev Vaccines2012，11，7：	1
6	Prostate cancer vaccines in clinical trials显示文摘	Lubaroff DM	2012	Expert Rev Vaccines2012，11，7：	1
7	Proposed mechanisms of action for prostate cancer vaccines显示文摘	Sean SM Lemke CD Lubaroff DM	2013	Nat Rev Urol2013，10，3：	1
8	Suppression of prostate cancer invasive potential and matrix metalloproteinase activity by E-cadherin transfection 显示文摘	Luo J Lubaroff DM Hendrix MJ	1999	Cancer Res1999，59，15：	1
9	R3327 adenocarcinoma of the Copenhagen rat as a model for the study of the immunologic aspects of prostate Cancer显示文摘	Lubaroff DM Canfield L Feldbush TL		0，，：	1
10	Alteration in constituent urinary proteins in response to bladder outlet obstruction in rats显示文摘	Burns JA Kreder KJ Lubaroff DM	1998	J Urol1998，159，5：	1
11	Suppression of prostate cancer invasive potential and matrix metallopreteinase activity by Ecadherin transfection显示文摘	Lubaroff DM Hendrix MJ	1999	Cancer Res1999，59，15：	1
12	Suppression of prostate cancer invasive potential and matrix metalloproteinase activity by E - cadherin transfection显示文摘	Lubaroff DM Hendrix MJ	1999	Cancer Res1999，59，：	1
13	Phase I clinical trial of an adenovirus/prostate-specific antigen vaccine for prostate cancer:safety and immunologic results显示文摘	Lubaroff DM Konety BR Link B	2009	Clin Cancer Res2009，15，：	1
14	CpG oligonueleotide as an adjuvant for the treatment of prostate cancer显示文摘	Lubaroff DM Karan D	2009	Adv Drug Deliv Dev2009，61，3：	1
15	Cutting edge:restoration of the ability to generate CTL in mice immune to adenovirus by delivery of virus in a collagen-based matrix显示文摘	Siemens DR Elzey BD Lubaroff DM	2001	J Immunol2001，166，2：	1
16	Phase Ⅰ clinical trial of an adenovirus/prostate-specific antigen vaccine for prostate Cancer:safety and immunologic results显示文摘	Lubaroff DM Konety BR Link B	2009	Clin Cancer Res2009，15，23：	1
17	Prostate cancer vaccines in clinical trials显示文摘	Lubaroff DM	2012	Expert Rev Vaccines2012，11，7：	1
18	The combina- tion of a low-dose chemotherapeutic agent, 5-fluorouracil, and an adenoviral tumor vaccine has a synergistic benefit on survi~'al in a tumor model system显示文摘	GEARY SM LEMKE CD LUBAROFF DM	2013	PLoS 0ne2013，8，67：	1
19	Prostate cancer vaccines in clinical trials显示文摘	Lubaroff DM		0，，：	1
20	Prostate cancer vaccines in clinical trials显示文摘	Lubaroff DM	2012	Expert Rev Vaccines2012，11，7：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示